Successful treatment for thrombotic thrombocytopenic purpura complicated with myeloperoxidase anti-neutrophil cytoplasmic autoantibody-associated vasculitis

NDT Plus

Volumn 3, Issue 3, 2010, Pages 279-281

  Yamauchi, Yoko ^a,b   Nagatoya, Katsuyuki ^b   Okuno, Ayako ^a   Fujii, Naohiko ^a   Inoue, Toru ^b  

^a Hyogo Prefectural Nishinomiya Hospital   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

myeloperoxidase anti neutrophil cytoplasmic autoantibody (MPO ANCA) associated vasculitis; plasma exchange (PE); thrombotic thrombocytopenic purpura (TTP)

Indexed keywords

METHYLPREDNISOLONE; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE;

ADULT; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; FEMALE; GLOMERULOPATHY; HEMODIALYSIS; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY FUNCTION; LABORATORY TEST; PLASMAPHERESIS; PRIORITY JOURNAL; THROMBOTIC THROMBOCYTOPENIC PURPURA; VASCULITIS;

EID: 77955968235     PISSN: 17530784     EISSN: 17530792     Source Type: Journal    
DOI: 10.1093/ndtplus/sfq013     Document Type: Article

References (10)

1. Hirsch DJ, Jindal KK, Trillo AA. Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis and thrombotic microangiopathy. Am J Kidney Dis 1995; 26: 385-386
2. Nagai K, Kotani T, Takeuchi T et al. Successful treatment of thrombotic thrombocytopenic purpura with repeated plasma exchange in a patient with microscopic polyangitis. Mod Rheumatol 2008; 18: 643-646
3. Wyllie BF, Garg AX, Macnab J et al. Thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome: a new index predicting response to plasma exchange. Br J Haematol 2006; 132: 204-209
4. Sato T, Hanaoka R, Ohshima M et al. Analyses of ADAMTS13 activity and its inhibitor in patients with thrombotic thrombocytopenic purpura secondary to connective tissue diseases: observations in a single hospital. Clin Exp Rheumatol 2006; 24: 454-455
5. Howard MA, Williams LA, Terrell DR et al. Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Transfusion 2006; 46: 154-156
6. von Baeyer H. Plasmapheresis in thrombotic microangiopathy-associated syndromes: review of outcome data derived from clinical trials and open studies. Ther Apher 2002; 6: 320-328
7. Remuzzi G. HUS and TTP: variable expression of a single entity. Kidney Int 1987; 32: 292-308
8. Amorosi EL, Ultmann JE. Thrombotic thrombocytopenic purpura: report of 16 cases and review of the literature. Medicine 1966; 45: 139-159
9. Moake JL. Thrombotic microangiopathies. N Engl J Med 2002; 347: 589-600
10. George JN. How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Blood 2000; 96: 1223-1229